152 related articles for article (PubMed ID: 24550454)
1. Distance to health services affects local-level vaccine efficacy for pneumococcal conjugate vaccine (PCV) among rural Filipino children.
Root ED; Lucero M; Nohynek H; Anthamatten P; Thomas DS; Tallo V; Tanskanen A; Quiambao BP; Puumalainen T; Lupisan SP; Ruutu P; Ladesma E; Williams GM; Riley I; Simões EA
Proc Natl Acad Sci U S A; 2014 Mar; 111(9):3520-5. PubMed ID: 24550454
[TBL] [Abstract][Full Text] [Related]
2. Distance to health services modifies the effect of an 11-valent pneumococcal vaccine on pneumonia risk among children less than 2 years of age in Bohol, Philippines.
Root ED; Lucero M; Nohynek H; Stubbs R; Tallo V; Lupisan SP; Sanvictores DM; Nillos LT; Simões EA;
Int J Epidemiol; 2017 Apr; 46(2):706-716. PubMed ID: 27605588
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of an 11-valent pneumococcal conjugate vaccine against radiologically confirmed pneumonia among children less than 2 years of age in the Philippines: a randomized, double-blind, placebo-controlled trial.
Lucero MG; Nohynek H; Williams G; Tallo V; Simões EA; Lupisan S; Sanvictores D; Forsyth S; Puumalainen T; Ugpo J; Lechago M; de Campo M; Abucejo-Ladesma E; Sombrero L; Nissinen A; Soininen A; Ruutu P; Riley I; Mäkelä HP
Pediatr Infect Dis J; 2009 Jun; 28(6):455-62. PubMed ID: 19483514
[TBL] [Abstract][Full Text] [Related]
4. Efficacy, safety and immunogenicity of a pneumococcal protein-based vaccine co-administered with 13-valent pneumococcal conjugate vaccine against acute otitis media in young children: A phase IIb randomized study.
Hammitt LL; Campbell JC; Borys D; Weatherholtz RC; Reid R; Goklish N; Moulton LH; Traskine M; Song Y; Swinnen K; Santosham M; O'Brien KL
Vaccine; 2019 Dec; 37(51):7482-7492. PubMed ID: 31629570
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial.
Cutts FT; Zaman SM; Enwere G; Jaffar S; Levine OS; Okoko JB; Oluwalana C; Vaughan A; Obaro SK; Leach A; McAdam KP; Biney E; Saaka M; Onwuchekwa U; Yallop F; Pierce NF; Greenwood BM; Adegbola RA;
Lancet; 2005 Mar 26-Apr 1; 365(9465):1139-46. PubMed ID: 15794968
[TBL] [Abstract][Full Text] [Related]
6. IgG antibody concentrations after immunization with 11-valent mixed-carrier pneumococcal conjugate vaccine in efficacy trial against pneumonia among Filipino infants.
Soininen A; Nohynek H; Lucero M; Jousimies K; Ugpo J; Williams G; Käyhty H;
Vaccine; 2009 May; 27(20):2680-8. PubMed ID: 19428879
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity and safety of a novel ten-valent pneumococcal conjugate vaccine in healthy infants in The Gambia: a phase 3, randomised, double-blind, non-inferiority trial.
Clarke E; Bashorun A; Adigweme I; Badjie Hydara M; Umesi A; Futa A; Ochoge M; Obayemi D; Edem B; Saidy-Jah E; Onwuchekwa C; Dhere R; Sethna V; Kampmann B; Goldblatt D; Taylor D; Andi-Lolo I; Hosken N; Antony K; Innis BL; Alderson MR; Lamola S
Lancet Infect Dis; 2021 Jun; 21(6):834-846. PubMed ID: 33516293
[TBL] [Abstract][Full Text] [Related]
8. Acute lower respiratory infections in Indigenous infants in Australia's Northern Territory across three eras of pneumococcal conjugate vaccine use (2006-15): a population-based cohort study.
Binks MJ; Beissbarth J; Oguoma VM; Pizzutto SJ; Leach AJ; Smith-Vaughan HC; McHugh L; Andrews RM; Webby R; Morris PS; Chang AB
Lancet Child Adolesc Health; 2020 Jun; 4(6):425-434. PubMed ID: 32450122
[TBL] [Abstract][Full Text] [Related]
9. Pneumococcal conjugate vaccines in the prevention of childhood pneumonia.
Ivády B
Acta Microbiol Immunol Hung; 2010 Mar; 57(1):1-13. PubMed ID: 20350875
[TBL] [Abstract][Full Text] [Related]
10. Pneumococcal Conjugate Vaccine Protection against Coronavirus-Associated Pneumonia Hospitalization in Children Living with and without HIV.
Nunes MC; Cutland CL; Klugman KP; Madhi SA
mBio; 2021 Jan; 12(1):. PubMed ID: 33419872
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of conjugate pneumococcal vaccination in Singapore: comparing estimates for 7-valent, 10-valent, and 13-valent vaccines.
Tyo KR; Rosen MM; Zeng W; Yap M; Pwee KH; Ang LW; Shepard DS
Vaccine; 2011 Sep; 29(38):6686-94. PubMed ID: 21745516
[TBL] [Abstract][Full Text] [Related]
12. [Prevention of Streptococcus pneumoniae (pneumococcal) infections in adults].
Ludwig E; Mészner Z;
Orv Hetil; 2014 Dec; 155(50):1996-2004. PubMed ID: 25481502
[TBL] [Abstract][Full Text] [Related]
13. The data management of a phase III efficacy trial of an 11-valent pneumococcal conjugate vaccine and related satellite studies conducted in the Philippines.
Sanvictores DH; Lucero MG; Nohynek H; Tallo VL; Tanskanen A; Nillos LT; Williams G;
BMC Res Notes; 2012 Jun; 5():274. PubMed ID: 22676626
[TBL] [Abstract][Full Text] [Related]
14. Pneumococcal conjugate vaccine--a health priority.
Zar HJ; Madhi SA
S Afr Med J; 2008 Jun; 98(6):463-7. PubMed ID: 18683380
[TBL] [Abstract][Full Text] [Related]
15. Radiology quality assurance in a developing country setting: the 11-valent pneumococcal conjugate vaccine trial, Bohol, Philippines.
Arcay JD; Ocampo AF; Solis RK; Oncog IB; Diaz AD; Epe AC; Cagadas R; Pabatang S; Ostensen H; Lucero MG;
Vaccine; 2007 Mar; 25(13):2528-32. PubMed ID: 17023097
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of pneumococcal conjugate vaccine against hospital admissions for pneumonia in Australian children: a retrospective, population-based, record-linked cohort study.
Fathima P; Gidding HF; McIntyre PB; Snelling TL; McCallum L; de Klerk N; Blyth CC; Liu B; Moore HC
Lancet Child Adolesc Health; 2019 Oct; 3(10):713-724. PubMed ID: 31439496
[TBL] [Abstract][Full Text] [Related]
17. Pneumonia hospitalisations in Scotland following the introduction of pneumococcal conjugate vaccination in young children.
Nair H; Watts AT; Williams LJ; Omer SB; Simpson CR; Willocks LJ; Cameron JC; Campbell H
BMC Infect Dis; 2016 Aug; 16():390. PubMed ID: 27506837
[TBL] [Abstract][Full Text] [Related]
18. Pneumococcal conjugate vaccines for preventing vaccine-type invasive pneumococcal disease and pneumonia with consolidation on x-ray in children under two years of age.
Lucero MG; Dulalia VE; Parreno RN; Lim-Quianzon DM; Nohynek H; Makela H; Williams G
Cochrane Database Syst Rev; 2004 Oct; (4):CD004977. PubMed ID: 15495133
[TBL] [Abstract][Full Text] [Related]
19. Impact of ten-valent pneumococcal conjugate vaccine on pneumonia in Finnish children in a nation-wide population-based study.
Palmu AA; Rinta-Kokko H; Nohynek H; Nuorti JP; Kilpi TM; Jokinen J
PLoS One; 2017; 12(3):e0172690. PubMed ID: 28249015
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia.
Black SB; Shinefield HR; Ling S; Hansen J; Fireman B; Spring D; Noyes J; Lewis E; Ray P; Lee J; Hackell J
Pediatr Infect Dis J; 2002 Sep; 21(9):810-5. PubMed ID: 12352800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
